BNP Paribas Financial Markets
PRNB

BNP Paribas Financial Markets’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,896
Closed -$590K – 4292
2020
Q3 		$590K Buy
5,896
+3,124
+113% +$278K ﹤0.01% 2116
2020
Q2 		$166K Sell
2,772
-17,602
-86% -$1.09M ﹤0.01% 2570
2020
Q1 		$1.21M Buy
20,374
+18,236
+853% +$1.06M ﹤0.01% 1789
2019
Q4 		$117K Buy
2,138
+251
+13% +$9.37K ﹤0.01% 3216
2019
Q3 		$53.3K Buy
1,887
+1,149
+156% +$42.1K ﹤0.01% 3443
2019
Q2 		$24.5K Sell
738
-449
-38% -$14K ﹤0.01% 3824
2019
Q1 		$40.4K Buy
+1,187
New +$37.8K ﹤0.01% 3622

BNP Paribas Financial Markets's PRNB Position: Q4 2020 in Review

BNP Paribas Financial Markets sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2020, closing a stake of 5,896 shares — an estimated $590K sold.

BNP Paribas Financial Markets first reported a position in PRNB in Q1 2019 and held it in 7 quarters. The position peaked at $1.21M in Q1 2020. 0 funds tracked by Wall St. Rank hold PRNB as of Q4 2020.

  • BNP Paribas Financial Markets reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,896 Principia Biopharma Inc. Common Stock shares in Q4 2020, an estimated $590K.
  • BNP Paribas Financial Markets first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • BNP Paribas Financial Markets's Principia Biopharma Inc. Common Stock position peaked at $1.21M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.